
Narmadaria Laboratories Private Limited
Produces pharmaceutical products and trades chemicals.
Produces pharmaceutical products and trades chemicals.
Narmadaria Laboratories Private Limited (NLPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 August 2017 (Seven years and six months 16 days old ). Its registered office is in Guntur, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Narmadaria Laboratories Private Limited India are Suneel Guntupalli as CFO and Srinivas Munduru as Ceo. Chirumamilla Rao, Narmada Chirumamilla, and Ashok Kamkananpati serve as directors at the Company.
Guntur, Andhra Pradesh, India
+91-XXXXXXXXXX
U24304AP2017PTC106547
106547
Private Limited Indian Non-Government Company
25 Aug 2017
30 Sep 2023
31 Mar 2023
Unlisted
Roc Vijayawada
Name | Designation | Appointment Date | Status |
---|---|---|---|
Chirumamilla Rao ![]() | Managing Director | 25-Aug-2017 | Current |
Suneel Guntupalli ![]() | CFO | 20-Sep-2017 | Current |
Srinivas Munduru ![]() | CEO | 20-Sep-2017 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Narmada Chirumamilla ![]() | Director | 25-Aug-2017 | Current |
Ashok Kamkananpati ![]() | Director | 25-Aug-2017 | Current |
Narmadaria Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 38.45% increase in profit. The company's net worth dipped by a decrease of 0.96%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
In 2023, Narmadaria Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Chirumamilla Rao and Narmada Chirumamilla are mutual person
Chirumamilla Rao, Narmada Chirumamilla and 1 more are mutual person
Chirumamilla Rao is a mutual person
Chirumamilla Rao is a mutual person
Narmada Chirumamilla and Ashok Kamkananpati are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Narmadaria Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Narmadaria Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narmadaria Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Narmadaria Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Narmadaria Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Vijayawada.
Suneel Kumar Guntupalli was appointed as a Cfo was appointed as a Cfo on 20 Sep 2017 & has been associated with this company since 7 years 5 months .
Srinivas Rao Munduru was appointed as a Ceo was appointed as a Ceo on 20 Sep 2017 & has been associated with this company since 7 years 5 months .
Chirumamilla Venkateswara Rao was appointed as a Managing Director was appointed as a Managing Director on 25 Aug 2017 & has been associated with this company since 7 years 6 months .
Narmada Chirumamilla was appointed as a Director was appointed as a Director on 25 Aug 2017 & has been associated with this company since 7 years 6 months .
Narmadaria Laboratories Private Limited was incorporated on 25 Aug 2017.
The authorized share capital of Narmadaria Laboratories Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 5 directors are associated with Narmadaria Laboratories Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Narmadaria Laboratories Private Limited is 11-11-2 Flat No. 404 Vijetha Apartments Ramireddypet, India, Narasaraopet, Andhra Pradesh, 522601.
The corporate identification number (CIN) of Narmadaria Laboratories Private Limited is U24304AP2017PTC106547 and the company number is 106547 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2023 indicates that The net worth of Narmadaria Laboratories Private Limited has experienced an downturn of -0.96%.
The most recent Balance Sheet for Narmadaria Laboratories Private Limited was filed with the ROC on 31 Mar 2023.
SG
SM
NM
SG